Skip Navigation


Cardiovascular Research Advance Access originally published online on September 20, 2007
Cardiovascular Research 2008 77(1):54-63; doi:10.1093/cvr/cvm023
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
77/1/54    most recent
cvm023v2
cvm023v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by McGaffin, K. R.
Right arrow Articles by O'Donnell, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGaffin, K. R.
Right arrow Articles by O'Donnell, C. P.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2007. For Permissions please email: journals.permissions@oxfordjournals.org

Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury

Kenneth R. McGaffin1,*, Cheuk-Kwan Sun2,{dagger}, Jennifer J. Rager1, Lia C. Romano2, Baobo Zou2, Michael A. Mathier1, Robert M. O'Doherty3, Charles F. McTiernan1 and Christopher P. O'Donnell2

1 Cardiovascular Institute, University of Pittsburgh Medical Center, 1750 Bioscience Tower, 200 Lothrop Street, Pittsburgh, PA 15213, USA
2 Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
3 Division of Endocrinology and Metabolism, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

* Corresponding author. Tel: +1 412 647 2345; fax: +1 412 383 8857. E-mail address: mcgaffinkr{at}upmc.edu

Aims: Leptin is elevated under conditions of both obesity and heart failure (HF), and activation of leptin receptor (ObR) signalling is known to increase in vivo cardiac contractility and to have anti-hypertrophic effects on the left ventricle (LV). However, it is unknown whether ObR signalling is altered in cardiomyocytes after myocardial infarction (MI) leading to HF, or if a deficiency in ObR signalling leads to worse HF.

Methods and results: In separate experimental protocols, C57BL/6J and leptin-deficient (ob/ob) mice underwent open-chest surgery to induce permanent left coronary artery ligation (CAL) or had a sham operation. Subgroups of ob/ob mice examined were lean (food-restricted), obese (food-ad libitum), and leptin repleted. Four weeks post-surgery, cardiac structure and function was examined by echocardiography, and the activation of cardiac leptin signalling was characterized through quantitative PCR, western blotting, and DNA-binding activities. CAL produced echocardiographic evidence of HF in C57BL/6J mice, elevated circulating leptin, increased cardiomyocyte leptin and ObR expression, and activated myocardial signal transducer and activator of transcription-3 (STAT3). In leptin-deficient ob/ob mice, whether lean or obese, CAL caused increased hypertrophy and dilation, decreased contractility of the LV, and worsened survival relative to wildtype or leptin-repleted mice after CAL. In ob/ob mice, activation of cardiac STAT3 signalling after CAL is enhanced in the presence of leptin and parallels the induction of the STAT3-responsive genes, tissue-inhibitor of metalloproteinase-1 and heat shock protein-70.

Conclusion: These data demonstrate that HF increases ObR signalling in cardiomyocytes and that activation of ObR signalling improves functional outcomes in chronic ischaemic injury leading to HF.

KEYWORDS Heart failure; Signal transduction; Ischaemia; Cytokines; Gene expression


Time for primary review 41 days

{dagger} Present address. Department of Surgery, Chang Gung University, Kaohsiung Medical Center, 123 Ta-Pai Road, Niao-Sung Hsiang, Kaohsiung Hsien 83301, Taiwan.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article

Leptin-induced cardiac hypertrophy: RhoAing a lipid raft down a protective p38 MAPK signalling stream?
Chris J. Pemberton
Cardiovasc Res 2008 77: 4-5. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
M. Karmazyn, D. M. Purdham, V. Rajapurohitam, and A. Zeidan
Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart
Cardiovasc Res, July 15, 2008; 79(2): 279 - 286.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. J. Pemberton
Leptin-induced cardiac hypertrophy: RhoAing a lipid raft down a protective p38 MAPK signalling stream?
Cardiovasc Res, January 1, 2008; 77(1): 4 - 5.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.